Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$8.32 - $15.45 $5,541 - $10,289
-666 Reduced 0.88%
74,691 $650,000
Q4 2023

Feb 13, 2024

SELL
$8.79 - $11.51 $5,484 - $7,182
-624 Reduced 0.82%
75,357 $862,000
Q3 2023

Nov 13, 2023

BUY
$8.25 - $11.35 $14,379 - $19,783
1,743 Added 2.35%
75,981 $731,000
Q2 2023

Aug 04, 2023

SELL
$10.1 - $11.6 $1,767 - $2,030
-175 Reduced 0.24%
74,238 $789,000
Q1 2023

May 12, 2023

BUY
$10.37 - $12.56 $3,681 - $4,458
355 Added 0.48%
74,413 $782,000
Q4 2022

Feb 10, 2023

SELL
$9.9 - $12.43 $5,603 - $7,035
-566 Reduced 0.76%
74,058 $917,000
Q3 2022

Nov 14, 2022

SELL
$10.14 - $12.38 $7,047 - $8,604
-695 Reduced 0.92%
74,624 $773,000
Q2 2022

Aug 12, 2022

BUY
$11.05 - $12.72 $26,973 - $31,049
2,441 Added 3.35%
75,319 $868,000
Q1 2022

May 13, 2022

SELL
$10.61 - $12.88 $54,418 - $66,061
-5,129 Reduced 6.58%
72,878 $917,000
Q4 2021

Feb 11, 2022

SELL
$10.86 - $13.95 $16,376 - $21,036
-1,508 Reduced 1.9%
78,007 $910,000
Q3 2021

Nov 12, 2021

SELL
$11.92 - $13.92 $22,516 - $26,294
-1,889 Reduced 2.32%
79,515 $1.04 Million
Q2 2021

Aug 13, 2021

SELL
$10.16 - $13.11 $422,341 - $544,969
-41,569 Reduced 33.8%
81,404 $1.05 Million
Q1 2021

May 07, 2021

SELL
$9.04 - $11.86 $33,728 - $44,249
-3,731 Reduced 2.94%
122,973 $1.38 Million
Q4 2020

Feb 12, 2021

BUY
$9.05 - $12.2 $283,102 - $381,640
31,282 Added 32.78%
126,704 $1.44 Million
Q3 2020

Nov 04, 2020

SELL
$8.99 - $10.74 $19,508 - $23,305
-2,170 Reduced 2.22%
95,422 $858,000
Q2 2020

Aug 12, 2020

BUY
$9.14 - $11.97 $46,623 - $61,058
5,101 Added 5.52%
97,592 $1.01 Million
Q1 2020

May 04, 2020

SELL
$8.58 - $14.01 $32,140 - $52,481
-3,746 Reduced 3.89%
92,491 $933,000
Q4 2019

Feb 05, 2020

SELL
$8.22 - $14.0 $6,649 - $11,326
-809 Reduced 0.83%
96,237 $1.28 Million
Q3 2019

Nov 08, 2019

SELL
$8.59 - $10.96 $5,815 - $7,419
-677 Reduced 0.69%
97,046 $833,000
Q2 2019

Aug 13, 2019

BUY
$9.8 - $12.89 $78,527 - $103,287
8,013 Added 8.93%
97,723 $1.07 Million
Q1 2019

May 06, 2019

SELL
$8.27 - $12.73 $24,049 - $37,018
-2,908 Reduced 3.14%
89,710 $1.21 Million
Q4 2018

Feb 13, 2019

BUY
$7.8 - $16.13 $5,553 - $11,484
712 Added 0.77%
92,618 $960,000
Q3 2018

Nov 09, 2018

BUY
$14.31 - $17.65 $23,697 - $29,228
1,656 Added 1.83%
91,906 $1.7 Million
Q2 2018

Aug 08, 2018

BUY
$11.83 - $16.2 $49,212 - $67,392
4,160 Added 4.83%
90,250 $1.73 Million
Q1 2018

May 07, 2018

SELL
$11.13 - $13.63 $51,543 - $63,120
-4,631 Reduced 5.1%
86,090 $1.33 Million
Q4 2017

Feb 09, 2018

BUY
$12.16 - $14.58 $5,228 - $6,269
430 Added 0.48%
90,721 $1.36 Million
Q3 2017

Nov 09, 2017

BUY
$12.07 - $14.87 $1.09 Million - $1.34 Million
90,291
90,291 $1.42 Million

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $562M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.